selected publications
-
academic article
- A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation.. Cognitive Behaviour Therapy. 48:65-76. 2018
- Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.. Journal of Dual Diagnosis. 13:168-178. 2017
- Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.. Addictive Behaviors. 89-95. 2017
- Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.. Schizophrenia Research. 124-129. 2016
- Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial.. Journal of Clinical Psychiatry. 77:e320-6. 2016
- Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness. J. Clin. Psychiatry. 2016
- Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.. JAMA. 311:145-54. 2014
- Long-term outcomes of a randomized trial of integrated skills training and preventive healthcare for older adults with serious mental illness.. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 22:1251-61. 2013
- Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness.. Journal of consulting and clinical psychology. 78:561-73. 2010
- Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects.. Journal of neurolinguistics. 23:297-317. 2010